Nusinersen improves walking distance and reduces fatigue in later-onset spinal muscular atrophy.

Introduction Ambulatory individuals with spinal muscular atrophy (SMA) experience muscle weakness, gait impairments, and fatigue that affect their walking ability. Improvements have been observed in motor function in children treated with nusinersen, but its impact on fatigue has not been studied.Me... View More